找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Delivery; Monika Sch?fer-Korting Book 2010 Springer-Verlag Berlin Heidelberg 2010 Biosensing.Drug Delivery.Drug-eluting implants.Nano

[復(fù)制鏈接]
樓主: Traction
11#
發(fā)表于 2025-3-23 09:46:25 | 只看該作者
Intrauterine Drug Delivery for Contraception and Gynaecological Treatment: Novel ApproachesIUDs/IUSs and framed LNG-IUS are the beginning of a series of innovative developments in this field. New compounds, such as progesterone antagonists and selective progesterone receptor modulators (SPRMs), could be incorporated into polymeric drug delivery platforms for use in the uterus, cervix, or
12#
發(fā)表于 2025-3-23 14:23:50 | 只看該作者
13#
發(fā)表于 2025-3-23 20:08:22 | 只看該作者
Book 2010overing today’s options for specific carrier systems allowing successful drug treatment at various sites of the body difficult to address and allowing to increase the benefit-risk-ratio to the optimum possible..
14#
發(fā)表于 2025-3-23 22:56:23 | 只看該作者
0171-2004 rious modern approaches to drug targeting covering today’s options for specific carrier systems allowing successful drug treatment at various sites of the body difficult to address and allowing to increase the benefit-risk-ratio to the optimum possible..978-3-642-26290-6978-3-642-00477-3Series ISSN 0171-2004 Series E-ISSN 1865-0325
15#
發(fā)表于 2025-3-24 06:06:13 | 只看該作者
16#
發(fā)表于 2025-3-24 06:30:09 | 只看該作者
Mucoadhesive Drug Delivery Systemsucus, the different mucoadhesion theories and binding types between mucus and mucoadhesives, mucoadhesion tests and factors influencing mucoadhesion are introduced. Various mucoadhesive polymers are also described and an overview of various mucoadhesive delivery systems is provided.
17#
發(fā)表于 2025-3-24 14:13:48 | 只看該作者
18#
發(fā)表于 2025-3-24 15:45:43 | 只看該作者
https://doi.org/10.1007/978-3-662-30424-2ssue. The construction and production of retrovirus, lentivirus, and AAV vectors are covered. The focus is on production methods suitable for biopharmaceutical upscaling and for downstream processing. Quality control measures and biological safety considerations for the use of vectors in clinical trials are discussed.
19#
發(fā)表于 2025-3-24 20:42:09 | 只看該作者
20#
發(fā)表于 2025-3-25 02:30:18 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 07:35
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
内黄县| 芦山县| 沧州市| 寿宁县| 信宜市| 北海市| 岑巩县| 焦作市| 连平县| 泸州市| 固始县| 壶关县| 云浮市| 儋州市| 克东县| 鲁甸县| 双城市| 佛山市| 周宁县| 泗水县| 东安县| 古浪县| 贺州市| 西乌| 确山县| 淮阳县| 赤壁市| 津南区| 岳阳市| 烟台市| 阳东县| 永泰县| 潮州市| 莲花县| 太谷县| 海兴县| 忻城县| 凤山县| 虞城县| 开封县| 嘉祥县|